INSMED Inc cotiza a 98.56 USD y tiene una capitalización bursátil de $21.5B. En los últimos 12 meses ha facturado $1.1B con un margen de flujo de caja libre del -159.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatm…
| Periodo | 2026-10 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.06 | $-0.76 | $-1.54 |
| Estimado | $-0.37 | $-0.68 | $-1.00 | $-1.17 |
| Sorpresa | — | +91.2% | +24.0% | -31.6% |
| Métrica | INSM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 79.7% | 57.0% | +22.7% |
| Operating Margin | -205.6% | -38.6% | -167.0% |
| Net Margin | -210.5% | -33.6% | -177.0% |
| FCF Margin | -159.6% | -13.9% | -145.7% |
| ROE | -172.8% | -40.4% | -132.4% |
| ROA | -56.4% | -32.0% | -24.4% |
| Current Ratio | 3.83 | 2.84 | +0.99 |
| Debt / Equity | 0.74 | 0.28 | +0.46 |